EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Trigeminal neuralgia - Overview

Olafur Arni Sveinsson, Enrico Bernardo Arkink, Elfar Ulfarsson, Brynhildur Thors

Laeknabladid · 10.02.2025 · 111 (02) · 62-67

DOI: 10.17992/lbl.2025.02.825 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Laeknabladid, online erschienen am 10.02.2025. Verfasst von Olafur Arni Sveinsson und 3 weiteren Autor:innen. Beteiligte Einrichtung: University Iceland, Faculty of Medicine, Department of Neurology, University Hospital of Iceland, Reykjavik, Iceland. Hauptthemen laut MEDLINE: Trigeminal Neuralgia. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trigeminal neuralgia is the most common cause of facial pain in individuals over 50 years old and can have a profoundly negative impact on quality of life. Epidemiological studies have measured the annual incidence of trigeminal neuralgia at around 4–5 cases per 100,000 inhabitants per year. In Iceland, this would amount to about 16–20 new cases annually. The incidence increases steadily with age, peaking between 50 and 70 years. The pain is sudden and often compared to an electric shock. The attacks usually occur in the second or third branches of the trigeminal nerve. The pain is often triggered by sensory stimulation. Chewing, brushing teeth, speaking, or exposure to cold wind on the face, can all trigger an attack. The most common cause of trigeminal neuralgia is believed to be pressure from a nearby blood vessel on the nerve at its origin in the brainstem. Other underlying causes include multiple sclerosis (MS), tumors and in some cases, no cause is found. Treatment for trigeminal neuralgia involves medication with drugs such as carbamazepine, oxcarbazepine, gabapentin, or various types of surgical procedures. This article will review the epidemiology, pathogenesis, clinical symptoms, diagnosis and treatment of trigeminal neuralgia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trigeminal NeuralgiaHumansIcelandRisk FactorsTreatment OutcomeIncidenceMiddle AgedPredictive Value of TestsAnalgesicsAged

Stichwörter der Autor:innen

percutaneous balloon compressioncarbamazepinemicrovascular decompressionoxcarbazepinetrigeminal neuralgia

Substanzen

Analgesics

Autor:innen und Institutionen

  • University Iceland, Faculty of Medicine, Department of Neurology, University Hospital of Iceland, Reykjavik, Iceland.
  • University Iceland, Faculty of Medicine, Department of Radiology, University Hospital of Iceland, Reykjavik, Iceland.
  • Department of Neurosurgery, University Hospital of Iceland, Reykjavik, Iceland.
  • Department of Neurology, University Hospital of Iceland, Reykjavik, Iceland.

Zitieren

APA

Sveinsson, O. A., Arkink, E. B., Ulfarsson, E., & Thors, B. (2025). Trigeminal neuralgia - Overview. Laeknabladid, 111(02), 62-67. https://doi.org/10.17992/lbl.2025.02.825

Vancouver

Sveinsson OA, Arkink EB, Ulfarsson E, Thors B. Trigeminal neuralgia - Overview. Laeknabladid. 2025;111(02):62-67. doi:10.17992/lbl.2025.02.825

BibTeX
@article{Sveinsson2025,
  author = {Sveinsson, Olafur Arni and Arkink, Enrico Bernardo and Ulfarsson, Elfar and Thors, Brynhildur},
  title = {Trigeminal neuralgia - Overview},
  journal = {Laeknabladid},
  year = {2025},
  volume = {111},
  number = {02},
  pages = {62--67},
  doi = {10.17992/lbl.2025.02.825}
}
Kostenlos starten →